Sichuan Kelun Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sichuan Kelun Pharmaceutical Company Limited with three other
companies in this sector in China:
Joincare Pharmaceutical Group Industry Company Limited
sales of 10.78 billion Chinese Renmimbi [US$1.56 billion]
of which 99%
was Industry and Commerce),
Harbin Pharmaceutical Group Company Limited
(12.02 billion Chinese Renmimbi [US$1.74 billion]
of which 66%
was Medicine Trade), and
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
(11.12 billion Chinese Renmimbi [US$1.61 billion]
of which 96%
Sichuan Kelun Pharmaceutical Company Limited reported sales of 11.43 billion Chinese Renmimbi (US$1.65 billion)
December of 2017.
increase of 33.5%
versus 2016, when the company's sales were 8.57 billion Chinese Renmimbi.
Sales of Medical and Pharmaceutical Products saw an increase
37.6% in 2017, from
8.23 billion Chinese Renmimbi to 11.33 billion Chinese Renmimbi.
Not all segments of Sichuan Kelun Pharmaceutical Company Limited experienced an increase in sales in 2017:
sales of Other Operating fell 68.6% to 104.39 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).